Assoz. Prof. Mag. Dr. Christian Kowol
Christian Kowol
Summer term 2023
270012 PR Elective Laboratory Course for Bachelor Module - Organic/Bioanorganic/Biological/Biophysical Chemistry
Summer term 2022
270012 PR Elective Laboratory Course for Bachelor Module - Organic/Bioanorganic/Biological/Biophysical Chemistry
270023 UE Inorganic Chemistry Lab course D - Inorganic Chemistry Lab course IIID - Coordination chemistry
270100 UE Inorganic Chemistry Lab course A - Inorganic Chemistry Lab course III A - Bioinorganic Chemistry, coordination chemistry
1 - 20 out of 115




Schwendenwein, A., Boettiger, K., Kovacs, I., Barany, N., Megyesfalvi, Z., Grusch, M., Kowol, C., Rezeli, M., Hoetzenecker, K., Dome, B., & Schelch, K. (2022). EP14.02-00 Cisplatin in Combination with Entinostat exerts Synergistic Antineoplastic Activity in Small Cell Lung Cancer. Journal of thoracic oncology, 17(9), S537-S537.

Posa, V., Stefanelli, A., Nunes, J. H. B., Hager, S., Mathuber, M., May, N., Berger, W., Keppler, B. K., Kowol, C. R., Enyedy, E. A., & Heffeter, P. (2022). Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance. Cancers, 14(18), [4455]. https://doi.org/10.3390/cancers14184455

Falcone, E., Ritacca, A. G., Hager, S., Schueffl, H., Vileno, B., El Khoury, Y., Hellwig, P., Kowol, C. R., Heffeter, P., Sicilia, E., & Faller, P. (2022). Copper-Catalyzed Glutathione Oxidation is Accelerated by the Anticancer Thiosemicarbazone Dp44mT and Further Boosted at Lower pH. Journal of the American Chemical Society, 144(32), 14758-14768. https://doi.org/10.1021/jacs.2c05355




Terenzi, A., La Franca, M., van Schoonhoven, S., Panchuk, R., Martinez, A., Heffeter, P., Gober, R., Pirker, C., Vician, P., Kowol, C. R., Stoika, R., Salassa, L., Rohr, J., & Berger, W. (2021). Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolism. Communications Chemistry, 4(1), [162]. https://doi.org/10.1038/s42004-021-00600-4




Mathuber, M., Gutmann, M., La Franca, M., Vician, P., Laemmerer, A., Moser, P., Keppler, B. K., Berger, W., & Kowol, C. R. (2021). Development of a cobalt(iii)-based ponatinib prodrug system. Inorganic Chemistry Frontiers, 8(10), 2468-2485. https://doi.org/10.1039/d1qi00211b


Mathuber, M., Schueffl, H., Dömötör, O., Karnthaler, C., Enyedy, É. A., Heffeter, P., Keppler, B. K., & Kowol, C. R. (2020). Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs. Inorganic Chemistry, 59(23), 17794-17810 . https://doi.org/10.1021/acs.inorgchem.0c03083




1 - 20 out of 115

Anticancer drug development: a chemist´s view

Christian Kowol (Invited speaker)

17 Nov 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Impact of albumin-targeting on the pharmacology, tissue distribution and anticancer activity of an oxaliplatin(IV) bismaleimide prodrug in vivo

Hemma Schueffl (Speaker), Sarah Theiner (Contributor), Gunda Köllensperger (Contributor), Bernhard Keppler (Contributor), Walter Berger (Contributor), Christian Kowol (Contributor), Anton Legin (Contributor) & Petra Heffeter (Speaker)

29 Jun 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Crucial Parameters for Platinum(IV) Anticancer Drug development

Christian Kowol (Invited speaker)

13 Jun 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Hydrolysis of equatorial ligands of platinum(IV) complexes

Alexander Kastner (Keynote speaker), Isabella Pötsch (Contributor), Petra Heffeter (Contributor), Bernhard Keppler (Contributor) & Christian Kowol (Contributor)

24 Sep 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Crucial parameters for platinum(IV) anticancer drug development

Christian Kowol (Keynote speaker)

30 Jun 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Aquation of equatorial ligands of Pt(IV) complexes under physiological conditions

Christian Kowol (Keynote speaker)

11 Jun 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Albumin-targeted platinum(IV) complexes with outstanding antitumor activity in vivo

Christian Kowol (Speaker)

26 Aug 2018

Activity: Talks and presentationsTalk or oral contributionScience to Science


Prodrugs and Tumor-specific Activation

Christian Kowol (Invited speaker)

24 Jun 2018

Activity: Talks and presentationsTalk or oral contributionScience to Science


Distinctly enhanced anticancer activity in vivo by albumin-targeted platinum(IV) prodrugs

Christian Kowol (Invited speaker)

14 Aug 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Metallomics and metabolomics studies in preclinical anticancer research of oxaliplatin

Luis Galvez (Speaker), Michaela Schwaiger (Contributor), Sonja Hager (Contributor), Christian Kowol (Contributor), Petra Heffeter (Contributor), Walter Berger (Contributor) & Gunda Köllensperger (Contributor)

14 Aug 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Albumin-based tumor-targeted platinum(IV) prodrugs with distinctly enhanced anticancer activity in vivo

Christian Kowol (Invited speaker)

12 Jul 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Understanding the metabolism of the anticancer drug Triapine by application of electrochemistry and liquid chromatography coupled to mass spectrometry

Karla Pelivan (Speaker), Lisa Frensemeier (Contributor), Uwe Karst (Contributor), Gunda Köllensperger (Contributor), Björn Bielec (Contributor), Petra Heffeter (Contributor), Christian Kowol (Contributor) & Bernhard Keppler (Contributor)

12 May 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Maleimid-functionalized Platinum(IV) complexes for tumor-Targeted Drug Delivery

Christian Kowol (Speaker)

28 Aug 2016

Activity: Talks and presentationsTalk or oral contributionOther


Tyrosine-kinase receptor targeted platinum(IV) complexes

Christian Kowol (Invited speaker)

28 Apr 2016

Activity: Talks and presentationsTalk or oral contributionOther


Prodrugs as the next step in drug development

Christian Kowol (Invited speaker)

2016

Activity: Talks and presentationsTalk or oral contributionScience to Science


Prodrug strategies for tumor-specific anticancer activity

Christian Kowol (Invited speaker)

7 Mar 2015

Activity: Talks and presentationsTalk or oral contributionOther


A COBALT-BASED PRODRUG STRATEGY FOR TUMOR-TARGETING OF EGFR-INHIBITORS

Christian Kowol (Invited speaker)

14 Dec 2014

Activity: Talks and presentationsTalk or oral contributionOther


The search for novel anticancer drugs

Christian Kowol (Invited speaker)

11 Oct 2013

Activity: Talks and presentationsTalk or oral contributionOther


Development and optimization of multifunctional nanoparticles for molecular imaging and therapy

Christian Kowol (Contributor)

28 Jun 2012

Activity: Talks and presentationsTalk or oral contributionOther


Marker für die Aktivität von Albumin-bindenden Verbindungen

Heffeter, P., Mindt, T. & Kowol, C.

1/08/2031/07/24

Project: Research funding



Nanocarrier for Tumor-Specific Anticancer Thiosemicarbazones

Kowol, C., Heffeter, P. & Teasdale, I.

1/05/1930/04/23

Project: Research funding


Prodrugs von Kinase-Inhibitoren

Kowol, C.

4/12/154/12/18

Project: Research funding


Tumor-targeting

Kowol, C.

9/12/138/12/16

Project: Research funding


Department of Inorganic Chemistry

Währinger Straße 42
1090 Wien
Room: 2164

T: +43-1-4277-52611

christian.kowol@univie.ac.at